Orion Market Research Pvt. Ltd. info@omrglobal.com +91 780-304-0404
Charge Forward: The Future of Driving is Electric
Published : May 2024
The Electric Vehicle market has offered numerous ways that are reshaping the automotive industry and driving the transition towards sustainable transportation solutions. One key benefit of EVs is their lower running costs compared to petrol and diesel-powered cars, with reduced maintenance expenses due to fewer moving components. EVs emit zero polluting gases, contributing to a cleaner environment and reduced carbon footprint. Owners of electric vehicles enjoy tax benefits, lower road tax, and registration fees, providing financial incentives for EV adoption. EVs are convenient to drive, gearless, and offer easy charging options at home, avoiding the need for frequent visits to fuel stations also providing a comfortable driving experience, with ample cabin space and storage options. Imp...
Economic slowdown: Massive Layoffs or Novel Job Opportunities
Published : Apr 2024
Present times mark the onset of the fourth industrial revolution. However, the economic slowdown experienced across the globe in the past is jeopardizing the esteemed progress towards the Sustainable Development Goals (SDGs). Although, the World Economic Situation and Prospects Report 2024, presents a sobering picture of the global economic landscape, backed by the outperformance of the global economic growth expectations in 2023, simmering geopolitical tensions and the growing intensity and frequency of extreme weather events are concerning the analysts and strategists. Additionally, amongst the remarkable resilience demonstrated by several major economies, the tight financial conditions still pose a risk to global trade and industrial production. Furthermore, the deceleration in globa...
Current Market Dynamics of AI Chatbots
Published : Apr 2024
Artificial Intelligence (AI) chatbots are revolutionizing customer service across industries. They keep the businesses connected to their customers across timelines and beyond time constraints. Thus chatbots are being increasingly adopted by businesses to improve customer experience and increase brand loyalty. AI chatbots play a pivotal role in various other business operations such as diverting human resources to core tasks, enabling smart messaging to add value to customer experience, assisting customers to make the right choice, upselling and recouping carts, and increasing personalization. AI chatbots also enable an effective reach to the millennial customer segment as they prefer to chat as against telephonic conversation. The use of chatbots allows for interactive marketing and al...
AI Chipsets: The FOMO Stock Rally
Published : Feb 2024
Artificial Intelligence (AI) is emerging as one of the most spoken-about novel technologies. It is evolving as a transformative force driving productive changes across industries. The boom in AI technology has developed a huge market opportunity for AI chipsets as they offer high-speed processing, low latency, and parallel computing capabilities to support the development and deployment of the AI infrastructure across various industries. AI chips offer energy efficiency, particularly in edge computing and IoT devices, and are suited for setups with power constraints. The AI chip market is anticipated to grow significantly at a CAGR of 40.5% by 2031. The market is majorly driven by the emerging trends in the automotive industry. The growing adoption of technologies such as AI and Machine...
Indigenous CAR-T cell therapy: A Paradigm Shift for B-Cell Cancer Treatment in India
Published : Feb 2024
Cancer has been one of the most dreaded diseases for years. The National Institute of Health, reported 14,61,427 (crude rate:100.4 per 100,000) number of incident cases of cancer in India for the year 2022. One in nine people in India is likely to develop cancer in his/her lifetime. Lung and breast cancers were found to be the leading sites of cancer in males and females, respectively. Children aged 0-14 years are more likely to suffer from lymphoid leukemia, with boys exhibiting a 29.2% incidence rate as against 24.2% for girls. Considering 2020, the incidence of cancer cases is estimated to grow by 12.8% by 2025. In 2020, Global Cancer Observatory (GLOBOCAN), estimated an incidence of 19.3 million cancer cases globally. As per the report, India ranked third after China and the US. Als...
Semiconductor Chips: Enhancing the Power of AI through Quantum Computing
Published : Feb 2024
Artificial Intelligence (AI) has made significant strides in recent years. Technology is redefining multiple industries including creation. The launch of AI tools such as ChatGPT, OwlyWriter AI, Dall-E, and more is redefining content creation. However, the processing of these AI algorithms requires advanced chips for efficient computing. AI algorithms are primarily based on Machine Learning (ML) and Deep Learning (DL) capabilities, which require a huge number of cores and Graphic Processing Units (GPUs) to work efficiently. In easy terms, the processing of complex AI algorithms requires the computing power of a supercomputer, and they are exorbitant and out of the reach of the masses. Thus, cloud computing and parallel processing have emerged as the most viable alternatives catering to ...
‘Nari Shakti’ is Truly Driving the Interim Budget
Published : Feb 2024
The Finance Minister Nirmala Sitharaman presented the interim budget on 1st February 2024. The budget is aimed at transforming India into 'Vikasit Bharat’. FM highlighted the budget focuses on four major pillars of developed India including, youth, poor, women, and farmers. In his prior budget address PM Modi announced that the budget would be driven by 'Nari Shakti'. Additionally, in her budget speech, the FM emphasized on social justice and inclusion. Thus, the budget announces some major welfare initiatives in line with this vision. The FM added that the Indian government is working with an all-round, all-pervasive, and all- inclusive development approach. It has been evident through the speech that social justice has emerged as a political slogan. The FM affirmed that social justice...
Interim Budget 2024: Expectations v/s Reality
Published : Feb 2024
Finance Minister (FM) Nirmala Sitharaman presented the interim budget- a short-term financial plan on February 1, 2024, in the parliament. The full budget would be presented by the new government, in July, after the Lok Sabha polls. The interim budget is the balanced budget and seeks Parliament's nod for a grant in advance to meet the government's essential expenditure for the first four months of the new financial year. In her speech, the FM confirmed the budget's focus on the four major pillars of developed India namely, the young, poor, women, and farmers. The budget is a representation of FM’s outlook to make India a ‘Vikasit Bharat’ by 2047. She added that the government could save INR2.7 lakh crore (around $32.5 billion) through avoidance of leakages. Review of the Past Performanc...
FDA Approvals Mark Major Advances in Cancer Treatment: Pembrolizumab Breakthroughs
Published : Jan 2024
In January 2024, the FDA achieved a significant milestone by approving two pivotal drugs for cancer treatment. On January 12, pembrolizumab (Keytruda, Merck), in combination with chemoradiotherapy, received FDA approval for the treatment of FIGO 2014 Stage III-IVA cervical cancer. This was followed by the successful approval of erdafitinib (Balversa, Janssen Biotech) on January 19, a drug designated for use in cases of locally advanced or metastatic urothelial carcinoma.Keytruda (Merck & Co) Worldwide Sales, 2021-2023 ($ Billion) Merck presently has numerous candidates undergoing regulatory review both in the United States and internationally, or they are in the advanced stages of clinical development. Keytruda (MK-3475), an anti-PD-1 therapy, has gained approval for treating various ca...
Growing Biopharma’s Top Line: Drugs
Published : Jan 2024
Keytruda surpassed Humira to become the leading product in 2023. The Comirnaty COVID-19 vaccine, which had previously displaced Humira in 2022, experienced a significant decline in sales during 2023. The introduction of biosimilars targeting AbbVie anti-rheumatic in the US in January 2023 contributed to the decline in sales for the year.Top Selling Drugs in 2023 ($ Million) KEYTRUDA is a prescribed medication employed in the treatment of triple-negative breast cancer (TNBC), melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell cancer (HNSCC), bladder and urinary tract cancer (urothelial carcinoma), and various other types of cancer. Merck reported Keytruda sales of $18 billion in the initial nine months of 2023. Sales for the first half of 2023 amounted to $12.07 bi...